Role of microglia in central nervous system infections

Clinical Microbiology Reviews

Volumn 17, Issue 4, 2004, Pages 942-964

  Rock, R Bryan ^a   Gekker, Genya ^a   Hu, Shuxian ^a   Sheng, Wen S ^a   Cheeran, Maxim ^a   Lokensgard, James R ^a   Peterson, Phillip K ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CATHEPSIN B; CATHEPSIN L; CHEMOKINE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYTOKINE; ELASTASE; FIBROBLAST GROWTH FACTOR; FREE RADICAL; GELATINASE A; GELATINASE B; GLUTAMIC ACID; GROWTH FACTOR; ICOSANOID; MATRIX METALLOPROTEINASE; MEMBRANE RECEPTOR; NERVE GROWTH FACTOR; NITRIC OXIDE; PLASMINOGEN; PROTEINASE; QUINOLINIC ACID; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SECRETORY PROTEIN; STROMELYSIN; SUPEROXIDE; UNINDEXED DRUG;

ACANTHAMOEBA CASTELLANII; BORRELIA BURGDORFERI; CELL ACTIVATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM INFECTION; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS; DEGENERATIVE DISEASE; HERPES SIMPLEX VIRUS; HISTORY OF MEDICINE; HOST PARASITE INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; INFLAMMATION; MICROGLIA; MYCOBACTERIUM TUBERCULOSIS; NOCARDIA ASTEROIDES; PLASMODIUM FALCIPARUM; PRION DISEASE; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TOXOPLASMA GONDII; TRYPANOSOMA BRUCEI; VIRUS;

ANIMALS; CENTRAL NERVOUS SYSTEM INFECTIONS; MICROGLIA; MONOCYTES; NEUROGLIA;

ACANTHAMOEBA; ACANTHAMOEBA CASTELLANII; BACTERIA (MICROORGANISMS); BORRELIA; BORRELIA BURGDORFERI; CYTOMEGALOVIRUS; FILOBASIDIELLA NEOFORMANS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NOCARDIA; NOCARDIA ASTEROIDES; PLASMODIUM FALCIPARUM; SIMPLEXVIRUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; TOXOPLASMA GONDII; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 5644271409     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.17.4.942-964.2004     Document Type: Review

References (386)

1. Adamson, D. C., B. Wildemann, M. Sasaki, J. D. Glass, J. C. McArthur, V. I. Christov, T. M. Dawson, and V. L. Dawson. 1996. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274:1917-1921.
2. Adle-Biassette, H., F. Chretien, L. Wingertsmann, C. Hery, T. Ereau, F. Scaravilli, M. Tardieu, and F. Gray. 1999. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25:123-133.
3. Aguirre, K., and S. Miller. 2002. MHC class II;-positive perivascular microglial cells mediate resistance to Cryptococcus neoformans brain infection. Glia 39:184-188.
4. Ajmone-Cat, M. A., A. Nicolini, and L. Minghetti. 2003. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. J. Neurochem. 87:1193-1203.
5. Albright, A. V., I. Frank, and F. Gonzalez-Scarano. 1999. Interleukin-2 treatment of microglia has no effect on in vitro HIV infection. AIDS 13:527-528.
6. Albright, A. V., J. Martin, M. O'Connor, and F. Gonzalez-Scarano. 2001. Interactions between HIV-1 gp120, chemokines, and cultured adult microglial cells. J. Neurovirol. 7:196-207.
7. Albright, A. V., J. T. Shieh, T. Itoh, B. Lee, D. Pleasure, M. J. O'Connor, R. W. Doms, and F. Gonzalez-Scarano. 1999. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J. Virol. 73:205-213.
8. Albright, A. V., J. T. Shieh, M. J. O'Connor, and F. Gonzalez-Scarano. 2000. Characterization of cultured microglia that can be infected by HIV-1. J. Neurovirol. 6(Suppl. 1):S53-S60.
9. Albright, A. V., J. Strizki, J. M. Harouse, E. Lavi, M. O'Connor, and F. Gonzalez-Scarano. 1996. HIV-1 infection of cultured human adult oligodendrocytes. Virology 217:211-219.
10. Aloisi, F. 1999. The role of microglia and astrocytes in CNS immune surveillance and immunopathology, p. 123-133. In R. Matsas and M. Tsacopoulos (ed.), Advances in experimental medicine and biology, vol. 468. The functional roles of glial cells in health and disease. Kluwer/Plenum Publishers, New York, N. Y.
11. Aloisi, F., G. Penna, J. Cerase, B. Menendez Iglesias, and L. Adorini. 1997. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159:1604-1612.
12. An, S. F., O. Osuntokun, M. Groves, and F. Scaravilli. 2001. Expression of CCR-5/CXCR-4 in spinal cord of patients with AIDS. Acta Neuropathol. 102:175-180.
13. Anders, K. H., W. F. Guerra, U. Tomiyasu, M. A. Verity, and H. V. Vinters. 1986. The neuropathology of AIDS. UCLA experience and review. Am. J. Pathol. 124:537-558.
14. Anthony, D. C., B. Ferguson, M. K. Matyzak, K. M. Miller, M. M. Esiri, and V. H. Perry. 1997. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 23:405-415.
15. Arribas, J. R., G. A. Storch, D. B. Clifford, and A. C. Tselis. 1996. Cytomegalovirus encephalitis. Ann. Intern. Med. 125:577-587.
16. Aurelius, E., B. Andersson, M. Forsgren, B. Skoldenberg, and O. Strannegard. 1994. Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. J Infect Dis 170:678-681.
17. Bacon, K. B., and J. K. Harrison. 2000. Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis. J. Neuroimmunol. 104:92-97.
18. Bagetta, G., M. T. Corasaniti, L. Berliocchi, R. Nistico, A. M. Giammarioli, W. Malorni, L. Aloe, and A. Finazzi-Agro. 1999. Involvement of interleukin-1beta in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat. Neuroscience 89:1051-1066.
19. Bajetto, A., R. Bonavia, S. Barbero, and G. Schettini. 2002. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 82:1311-1329.
20. Baker, C A., and L. Manuelidis. 2003. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 100: 675-679.
21. Baker, C. A., D. Martin, and L. Manuelidis. 2002. Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J. Virol. 76:10905-10913.
22. Bamberger, M. E., and G. E. Landreth. 2001. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease. Microsc. Res. Tech. 54:59-70.
23. Banati, R. B. 2003. Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain. Br. Med. Bull. 65:121-131.
24. Banati, R. B. 2002. Visualising microglial activation in vivo. Glia 40:206-217.
25. Banati, R. B., J. Gehrmann. P. Schubert, and G. W. Kreutzberg. 1993. Cytotoxicity of microglia. Glia 7:111-118.
26. Banisadr, G., F. Queraud-Lesaux, M. C. Boutterin, D. Pelaprat, B. Zalc, W. Rostene, F. Haour, and S. M. Parsadaniantz. 2002. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J. Neurochem. 81:257-269.
27. Barren, K. D. 1995. The microglial cell. A historical review. J. Neurol. Sci. 134(Suppl.):57-68.
28. Bate, C., R. S. Boshuizen, J. P. Langeveld, and A. Williams. 2002. Temporal and spatial relationship between the death of PrP-damaged neurones and microglial activation. Neuroreport 13:1695-1700.
29. Beaman, B. L. 1993. Ultrastructural analysis of growth of Nocardia asteraides during invasion of the murine brain. Infect. Immun. 61:274-283.
30. Beaman, L., and B. L. Beaman. 1993. Interactions of Nocardia asteroides with murine glia cells in culture. Infect. Immun. 61:343-347.
31. Becher, B., V. Dodelet, V. Fedorowicz, and J. Antel. 1996. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Investig. 98:1539-1543.
32. Benedetto, N., and C. Auriault. 2002. Complex network of cytokines activating murine microglial cell activity against Acanthamoeba castellani. Eur. Cytokine Netw. 13:351-357.
33. Benedetto, N., and C. Auriault. 2002. Prolactin-cytokine network in the defence against Acanthamoeba castellani in murine microglia. Eur. Cytokine Netw. 13:447-455.
34. Benedetto, N., F. Rossano, F. Gorga, A. Folgore, M. Rao, and C. Romano Carratelli. 2003. Defense mechanisms of IFN-gamma and LPS-primed murine microglia against Acanthamoeba castellanii infection. Int. Immunopharmacol. 3:825-834.
35. Benveniste, E. N., V. T. Nguyen, and G. M. O'Keefe. 2001. Immunological aspects of microglia: Relevance to Alzheimer's disease: Neurochem. Int. 39:381-391.
36. Berman, N. E., J. K. Marcario, C. Yong, R. Raghavan, L. A. Raymond, S. V. Joag, O. Narayan, and P. D. Cheney. 1999. Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes. Neurobiol. Dis. 6:486-498.
37. Betmouni, S., V. H. Perry, and J. L. Gordon. 1996. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 74:1-5.
38. Bezzi, P., M. Domercq, L. Brambilla, R. Galli, D. Schols, E. De Clercq, A. Vescovi, G. Bagetta, G. Kollias, J. Meldolesi, and A. Volterra. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4:702-710.
39. Blasi, E., R. Barluzzi, R. Mazzolla, B. Tancini, S. Saleppico, M. Puliti, L. Pitzurra, and F. Bistoni. 1995. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J. Neuroimmunol. 58:111-116.
40. Boddeke, E. W., I. Meigel, S. Frentzel, K. Biber, L. Q. Renn, and P. Gebicke-Harter. 1999. Functional expression of the fractaikine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia. Eur. J. Pharmacol. 374:309-313.
41. Bonwetsch, R., S. Croul, M. W. Richardson, C. Lorenzana, L. D. Valle, A. E. Sverstiuk, S. Amini, S. Morgello, K. Khalili, and J. Rappaport. 1999. Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. J. Neurovirol. 5:685-694.
42. Brandner, S. 2003. CNS pathogenesis of prion diseases. Br. Med. Bull. 66:131-139.
43. Braun, J. S., R. Novak, K. H. Herzog, S. M. Bodner, J. L, Cleveland, and E. I. Tuomanen. 1999. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat. Med. 5:298-302.
44. Braun, J. S., R. Novak, P. J. Murray, C. M. Eischen, S. A. Susin, G. Kroemer, A. Halle, J. R. Weber, E. I. Tuomanen, and J. L. Cleveland. 2001. Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J. Infect. Dis. 184:1300-1309.
45. 2 mediate brain cell apoptosis during meningitis. J. Clin. Investig. 109:19-27.
46. Brenneman, D. E., G. L. Westbrook, S. P. Fitzgerald, D. L. Ennist, K. L. Elkins, M. R. Ruff, and C. B. Peri. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639-642.
47. Brosnan, C. F., L. Battistini, C. S. Raine, D. W. Dickson, A. Casadevall, and S. C. Lee. 1994. Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 16:152-161.
48. Brown, D. R. 2001. Microglia and prion disease. Microsc. Res. Tech. 54: 71-80.
49. Brown, D. R., A. Besinger, J. W. Herms, and H. A. Kretzschmar. 1998. Microglial expression of the prion protein. Neuroreport 9:1425-1429.
50. Brown, D. R., and C. M. Mohn. 1999. Astrocytic glutamate uptake and prion protein expression. Glia 25:282-292.
51. Brown, D. R., B. Schmidt, and H. A. Kretzschmar. 1996. A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia 18:59-67.
52. Brown, D. R., B. Schmidt, and H. A. Kretzschmar. 1996. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380:345-347.
53. Brown, H., G. Turner, S. Rogerson, M. Tembo, J. Mwenechanya, M, Molyneux, and T. Taylor. 1999. Cytokine expression in the brain in human cerebral malaria. J. Infect. Dis. 180:1742-1746.
54. Bsibsi, M., R. Ravid, D. Gveric, and J. M. van Noort. 2002. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61:1013-1021.
55. Budka, H. 2003. Neuropathology of prion diseases. Br. Med. Bull. 66:121-130.
56. Byrd, T., and P. Zinser. 2001. Tuberculosis meningitis. Curr. Treat. Options Neurol. 3:427-432.
57. Cagnin, A., D. J. Brooks, A. M. Kennedy, R. N. Gunn, R. Myers, F. E. Turkheimer, T. Jones, and R. B. Banati. 2001. In-vivo measurement of activated microglia in dementia. Lancet 358:461-467.
58. Cagnin, A., R. Myers, R. N. Gunn, A. D. Lawrence, T. Stevens, G. W. Kreutzberg, T. Jones, and R. B. Banati. 2001. In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124:2014-2027.
59. Cantin, E. M., D. R. Hinton, J. Chen, and H. Openshaw. 1995. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:4898-4905.
60. Chang, R. C., C. Rota, R. E. Glover, R. P. Mason, and J. S. Hong. 2000. A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: a study by electron paramagnetic resonance spectroscopy. Brain Res. 854:224-229.
61. Chao, C., S. Hu, and P. Peterson. 1997. Glia-mediated neurotoxicity, p. 74-89. In P. Peterson and J. S. Remington (ed.), In defense of the brain: current concepts in the immunopathogenesis and clinical aspects of CNS infections. Blackwell Science, Maiden, Mass.
62. Chao, C. C., W. R. Anderson, S. Hu, G. Gekker, A. Martella, and P. K. Peterson. 1993. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin. Immunol. Immunopathol. 67:178-183.
63. Chao, C. C., G. Gekker, S. Hu, F. Kravitz, and P. K. Peterson. 1998. Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures. Biochem. Pharmacol. 56:397-404.
64. Chao, C. C., G. Gekker, S. Hu, and P. K. Peterson. 1994. Human microglial cell defense against Toxoplasma gondii. The role of cytokines. J. Immunol. 152:1246-1252.
65. Chao, C. C., G. Gekker, S. Hu, W. S. Sheng, K. B. Shark, D. F. Bu, S. Archer, J. M. Bidlack, and P. K. Peterson. 1996. Kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression. Proc. Natl. Acad. Sci. USA 93:8051-8056.
66. Chao, C. C., and S. Hu. 1994. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16:172-179.
67. Chao, C. C., S. Hu, K. Close, C. S. Choi, T. W. Molitor, W. J. Novick, and P. K. Peterson. 1992. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect. Dis. 166:847-853.
68. Chao, C. C., S. Hu, L. Ehrlich, and P. K. Peterson. 1995. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immun. 9:355-365.
69. Chao, C. C., S. Hu, G. Gekker, J. R. Lokensgard, M. P. Heyes, and P. K. Peterson. 2000. U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression. Neuropharmacology 39:150-160.
70. Chao, C. C., S. Hu, G. Gekker, W. J. Novick, Jr., J. S. Remington, and P. K. Peterson. 1993. Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. J. Immunol. 150:3404-3410.
71. Chao, C. C., S. Hu, T. W. Molitor, E. G. Shaskan, and P. K. Peterson. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:2736-2741.
72. Chao, C. C., S. Hu, K. B. Shark, W. S. Sheng, G. Gekker, and P. K. Peterson. 1997. Activation of mu opioid receptors inhibits microglial cell chemotaxis. J. Pharmacol. Exp. Ther. 281:998-1004.
73. Chauvet, N., K. Palin, D. Verrier, S. Poole, R. Dantzer, and J. Lestage. 2001. Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide. Eur. J. Neurosci. 14:609-617.
74. Cheeran, M. C., S. Hu, G. Gekker, and J. R. Lokensgard. 2000. Decreased cytomegalovirus expression following proinflammatory cytokine treatment of primary human astrocytes. J. Immunol. 164:926-933.
75. Cheeran, M. C., S. Hu, W. S. Sheng, P. K. Peterson, and J. R. Lokensgard. 2003. CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J. Virol. 77:4502-4515.
76. Cheeran, M. C., S. Hu, S. L. Yager, G. Gekker, P. K. Peterson, and J. R. Lokensgard. 2001. Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J. Neurovirol. 7:135-147.
77. Chen, S., D. Luo, W. J. Streit, and J. K. Harrison. 2002. TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J. Neuroimmunol. 133:46-55.
78. Chesebro, B. 2003. Introduction to the transmissible spongiform encephalopathies or prion diseases. Br. Med. Bull. 66:1-20.
79. Chianella, S., M. Semprevivo, Z. C. Peng, D. Zaccheo, M. Bentivoglio, and G. Grassi-Zucconi. 1999. Microglia activation in a model of sleep disorder: an immunohistochemical study in the rat brain during Trypanosoma brucei infection. Brain Res. 832:54-62.
80. Chiang, C. S., H. C. Powell, L. H. Gold, A. Samimi, and I. L. Campbell. 1996. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J. Clin. Investig. 97:1512-1524.
81. Colton, C. A., and D. L. Gilberg. 1987. Production of super-oxide anions by a CNS macrophage, the microglia. Eur. J. Biochem. 223:284-288.
82. Cosema, M. A., M. L. Zhao, Q. Si, and S. C. Lee. 2002. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol. 12:442-455.
83. Cotter, R., C. Williams, L. Ryan, D. Erichsen, A. Lopez, H. Peng, and J. Zheng. 2002. Fractalkine (CX3CL1) and brain inflammation: implications for HIV-1-associated dementia. J. Neurovirol. 8:585-598.
84. Cowell, R. M., and F. S. Silverstein. 2003. Developmental changes in the expression of chemokine receptor CCR1 in the rat cerebellum. J. Comp. Neurol. 457:7-23.
85. Cross, A. K., and M. N. Woodroofe. 1999. Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro. Glia 28:183-189.
86. Cross, A. K., and M. N. Woodroofe. 2001. Immunoregulation of microglial functional properties. Microsc. Res. Tech. 54:10-17.
87. Curto, M., C. Reali, G. Palmieri, F. Scintu, M. L. Schivo, V. Sogos, M. A. Marcialis, M. G. Ennas, H. Schwarz, G. Pozzi, and F. Gremo. 2004. Inhibition of cytokines expression in human microglia infected by virulent and non-virulent mycobacteria. Neurochem. Int. 44:381-392.
88. da Cunha, A., J. J. Jefferson, W. R. Tyor, J. D. Glass, F. S. Jannotta, J. R. Cottrell, and J. H. Resau. 1997. Transforming growth factor-beta1 in adult human microglia and its stimulated production by interleukin-1. J. Interferon Cytokine Res. 17:655-664.
89. Dalmau, I, J. M. Vela, B. Gonzalez, B. Finsen, and B. Castellano. 2003. Dynamics of microglia in the developing rat brain. J. Comp. Neurol. 458: 144-157.
90. Davis, L. E., B. L. Hjelle, V. E. Miller, D. L. Palmer, A. L. Llewellyn, T. L. Merlin, S. A. Young, R. G. Mills, W. Wachsman, and C. A. Wiley. 1992. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42:1736-1739.
91. Deckert-Schlüter, M., H. Bluethmann, N. Kaefer, A. Rang, and D. Schluter. 1999. Interferon-gamma receptor-mediated but not tumor necrosis factor receptor type 1- or type 2-mediated signaling is crucial for the activation of cerebral blood vessel endothelial cells and microglia in murine Toxoplasma encephalitis. Am. J. Pathol. 154:1549-1561.
92. Deckert-Schlüter, M., H. Bluethmann, A. Rang, H. Hof, and D. Schluter. 1998. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J. Immunol. 160:3427-3436.
93. Deckert-Schlüter, M., C. Buck, D. Weiner, N. Kaefer, A. Rang, H. Hof, O. D. Wiestler, and D. Schluter. 1997. Interleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis. J. Neuroimmunol. 76:167-176.
94. De Groot, C. J., and M. N. Woodroofe. 2001. The role of chemokines and chemokine receptors in CNS inflammation. Prog. Brain Res. 132:533-544.
95. Deininger, M. H., P. G. Kremsner, R. Meyermann, and H. Schluesener. 2002. Macrophages/microglial cells in patients with cerebral malaria. Eur. Cytokine Netw. 13:173-185.
96. Delgado, M., G. M. Jonakait, and D. Ganea. 2002. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia. Glia 39:148-161.
97. del Rio-Hortega, P. 1932. Microglia, p. 483-534. In W. Penfield (ed.), Cytology and cellular pathology of the nervous system. P. B. Hoebaer, New York, N.Y.
98. Diedrich, J. F., H. Minnigan, R. I. Carp, J. N. Whitaker, R. Race, W. Frey, Jr., and A. T. Haase. 1991. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65:4759-4768.
99. Ding, M., B. A. St. Pierre, J. F. Parkinson, P. Medberry, J. L. Wong, N. E. Rogers, L. J. Ignarro, and J. E. Merrill. 1997. Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia. J. Biol. Chem. 272:11327-11335.
100. Dobbie, M., J. Crawley, C. Waruiru, K. Marsh, and R. Surtees. 2000. Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism? Am. J. Trop. Med. Hyg. 62:284-290.
101. Durand, M. L., S. B. Calderwood, D. J. Weber, S. I. Miller, F. S. Southwick, V. S. Caviness, Jr., and M. N. Swartz. 1993. Acute bacterial meningitis in adults. A review of 493 episodes. N. Engl. J. Med. 328:21-28.
102. Ehrlich, L. C., S. Hu, P. K. Peterson, and C. C. Chao. 1998. IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation. Neuroreport 9:1723-1726.
103. Ehrlich, L. C., S. Hu, W. S. Sheng, R. L. Sutton, G. L. Rockswold, P. K. Peterson, and C. C. Chao. 1998. Cytokine regulation of human microglial cell IL-8 production. J. Immunol. 160:1944-1948.
104. Ekdahl, C. T., J.-H. Claasen, S. Bonde, Z. Kokaia, and O. Lindvall. 2003. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA 100:13632-13637.
105. Esiri, M. M., C. W. Drummond, and C. S. Morris. 1995. Macrophages and microglia in HSV-1 infected mouse brain. J. Neuroimmunol. 62:201-205.
106. Fauser, S., M. H. Deininger, P. G. Kremsner, V. Magdolen, T. Luther, R. Meyermann, and H. J. Schluesener. 2000. Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria. J. Neuroimmunol. 111:234-240.
107. Filipovic, R., I. Jacovcevski, and N. Zecevic. 2003. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev. Neurosci. 25:279-290.
108. Fischer, H. G., A. K. Bielinsky, B. Nitzgen, W. Daubener, and V. Hadding. 1993. Functional dichotomy of mouse microglia developed in vitro: differential effects of macrophage and granulocyte/macrophage colony-stimulating factor on cytokine secretion and antitoxoplasmic activity. J. Neuroimmunol. 45:193-201.
109. Fischer, H. G., B. Nitzgen, G. Reichmann, U. Gross, and U. Hadding. 1997. Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol. Res. 83:637-641.
110. Fischer, H.-G., and G. Reichmann. 2001. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 166: 2717-2726.
111. + peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. Neurovirol. 7:528-541.
112. Flynn, G., S. Maru, J. Loughlin, I. A. Romero, and D. Male. 2003. Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136:84-93.
113. Forloni, G., N. Angeretti, R. Chiesa, E. Monzani, M. Salmona, O. Bugiani, and F. Tagliavini. 1993. Neurotoxicity of a prion protein fragment. Nature 362:543-546.
114. Forloni, G., R. Del Bo, N. Angeretti, R. Chiesa, S. Smiroldo, R. Doni, E. Ghibaudi, M. Salmona, M. Porro, L. Verga, et al. 1994. A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur. J. Neurosci. 6:1415-1422.
115. Freund, Y. R., N. T. Zaveri, and H. S. Javitz. 2001. In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca mice. Infect. Immun. 69:765-772.
116. Gabuzda, D., J. He, A. Ohagen, and A. V. Vallat. 1998. Chemokine receptors in HIV-1 infection of the central nervous system. Semin. Immunol. 10:203-213.
117. Galea, E., D. J. Reis, E. S. Fox, H. Xu, and D. L. Feinstein. 1996. CD14 mediate endotoxin induction of nitric oxide synthase in cultured brain glial cells. J. Neuroimmunol. 64:19-28.
118. Gao, H. M., J. Jiang, B. Wilson, W. Zhang, J. S. Hong, and B. Liu. 2002. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81:1285-1297.
119. Gao, H. M., B. Liu, W. Zhang, and J. S. Hong. 2003. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J. 17:1954-1956.
120. Gartner, S., and Y. Liu. 2002. Insights into the role of immune activation in HIV neuropathogenesis. J. Neurovirol. 8:69-75.
121. Gehrmann, J., and G. W. Kreutzberg. 1995. Microglia in experimental neuropathology, p. 883-904. In H. Kentenmann and B. R. Ransom (ed.), Neuroglia. Oxford University Press, New York, N.Y.
122. Gehrmann, J., Y. Matsumoto, and G. W. Kreutzberg. 1995. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Rev. 20:269-287.
123. Gelbard, H. A., H. S. Nottet, S. Swindells, M. Jett, K. A. Dzenko, P. Genis, R. White, L. Wang, Y. B. Choi, D. Zhang, et al. 1994. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:4628-4635.
124. Ghorpade, A., R. Persidskaia, R. Suryadevara, M. Che, X. J. Lin, Y. Persidsky, and H. E. Gendelman. 2001. Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 75:6572-6583.
125. Ghorpade, A., M. Q. Xia, B. T. Hyman, Y. Persidsky, A. Nukuna, P. Bock, M. Che, J. Limoges, H. E. Gendelman, and C. R. Mackay. 1998. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol. 72:3351-3361.
126. Giese, A., D. R. Brown, M. H. Groschup, C. Feldmann, I. Haist, and H. A. Kretzschmar. 1998. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8:449-457.
127. Girard, M., Z. Ayed, P. M. Preux, B. Bouteille, J. L. Preud'Homme, M. Dumas, and M. O. Jauberteau. 2000. In vitro induction of nitric oxide synthase in astrocytes and microglia by Trypanosoma brucei brucei. Parasite Immunol. 22:7-12.
128. Girard, M., S. Bisser, B. Courtioux, C. Vermot-Desroches, B. Bouteille, J. Wijdenes, J. L. Preud'homme, and M. O. Jauberteau. 2003. In vitro induction of microglial and endothelial cell apoptosis by cerebrospinal fluids from patients with human African trypanosomiasis. Int. J. Parasitol. 33: 713-720.
129. Giulian, D. 1995. Microglia and neuronal dysfunction, p. 671-684. In H. Kentenmann and B. R. Ransom (ed.), Neuroglia. Oxford University Press, New York, N.Y.
130. Giulian, D., M. Corpuz, S. Chapman, M. Mansouri, and C. Robertson. 1993. Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J. Neurosci. Res. 36: 681-693.
131. Glass, J. D., H. Fedor, S. L. Wesselingh, and J. C. McArthur. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:755-762.
132. Glass, J. D., and S. L. Wesselingh. 2001. Microglia in HIV-associated neurological diseases. Microsc. Res. Tech. 54:95-105.
133. Goldman, D., X. Song, R. Kitai, A. Casadevall, M. L. Zhao, and S. C. Lee. 2001. Cryptococcus neoformans induces macrophage inflammatory protein 1α (MIP-1α) and MIP-1β in human microglia: role of specific antibody and soluble capsular polysaccharide. Infect. Immun. 69:1808-1815.
134. Goldman, D. L., B. C. Fries, S. P. Franzot, L. Montella, and A. Casadevall. 1998. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc. Natl. Acad. Sci. USA 95:14967-14972.
135. Gottschall, P. E., and S. Deb. 1996. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3:69-75.
136. Gottschall, P. E., X. Yu, and B. Bing. 1995. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. 3. Neurosci. Res. 42:335-342.
137. Gras, G., F. Chretien, A. V. Vallat-Decouvelaere, G. Le Pavec, F. Porcheray, C. Bossuet, C. Leone, P. Mialocq, N. Dereuddre-Bosquet, P. Clayette, R. Le Grand, C. Creminon, D. Dormant, A. C. Rimaniol, and F. Gray. 2003. Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol. 13:211-222.
138. Grassi, M. P., F. Clerici, C. Perin, A. D'Arminio Monforte, L. Vago, M. Borella, R. Boldorini, and A. Mangoni. 1998. Microglial nodular encephalitis and ventriculoencephalitis due to cytomegalovirus infection in patients with AIDS: two distinct clinical patterns. Clin. Infect. Dis. 27:504-508.
139. Greenlee, J. E., and J. W. Rose. 2000. Controversies in neurological infectious diseases. Semin. Neurol. 20:375-386.
140. Hafiz, F. B., and D. R. Brown. 2000. A model for the mechanism of astrogliosis in prion disease. Mol. Cell. Neurosci. 16:221-232.
141. Halford, W. P., B. M. Gebhardt, and D. J. Carr. 1996. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157:3542-3549.
142. Halliday, G., S. R. Robinson, C. Shepherd, and J. Kril. 2000. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Clin. Exp. Pharmacol. Physiol. 27:1-8.
143. Hanisch, U. K. 2002. Microglia as a source and target of cytokines. Glia 40:140-155.
144. Hanisch, U. K., M. Prinz, K. Angstwurm, K. G. Hausler, O. Kann, H. Kettenmann, and J. R. Weber. 2001. The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur. J. Immunol. 31:2104-2115.
145. Harrison, J. K., Y. Jiang, S. Chen, Y. Xia, D. Maciejewski, R. K. McNamara, W. J. Streit, M. N. Salafranca, S. Adhikari, D. A. Thompson, P. Botti, K. B. Bacon, and L. Feng. 1998. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 95:10896-10901.
146. Hausler, K. G., M. Prinz, C. Nolte, J. R. Weber, R. R. Schumann, H. Kettenmann, and U. K. Hanisch. 2002. Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur. J. Neurosci. 16:2113-2122.
147. He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, C. R. Mackay, J. Sodroski, and D. Gabuzda. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645-649.
148. Hegg, C. C., S. Hu, P. K. Peterson, and S. A. Thayer. 2000. Beta-chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia. Neuroscience 98:191-199.
149. Hesselgesser, J., and R. Horuk. 1999. Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol. 5:13-26.
150. Heyes, M. P., B. J. Brew, A. Martin, R. W. Price, A. M. Salazar, J. J. Sidtis, J. A. Yergey, M. M. Mouradian, A. E. Sadler, J. Keilp, et al. 1991. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:202-209.
151. Hickey, W. F. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36:118-124.
152. + T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans. 3. Immunol. 152:2344-2350.
153. Ho, W. Z., L. Song, and S. D. Douglas. 1991. Human cytomegalovirus infection and trans-activation of HIV-1 LTR in human brain-derived cells. J. Acquir. Immune Defic. Syndr. 4:1098-1106.
154. Hornig, M., H. Weissenbock, N. Horscroft, and W. I. Lipkin. 1999. An infection-based model of neurodevelopmental damage. Proc. Natl. Acad. Sci. USA 96:12102-12107.
155. Howe, D. K., and L. D. Sibley. 1995. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 172:1561-1566.
156. Hu, S., C. C. Chao, L. C. Ehrlich, W. S. Sheng, R. L. Sutton, G. L. Rockswold, and P. K. Peterson. 1999. Inhibition of microglial cell RANTES production by IL-10 and TGF-beta. J. Leukoc. Biol. 65:815-821.
157. Hu, S., C. C. Chao, C. C. Hegg, S. Thayer, and P. K. Peterson. 2000. Morphine inhibits human microglial cell production of, and migration towards, RANTES. J. Psychopharmacol. 14:238-243.
158. Hu, S., C. C. Chao, K. V. Khanna, G. Gekker, P. K. Peterson, and T. W. Molitor. 1996. Cytokine and free radical production by porcine microglia. Clin. Immunol. Immunopathol. 78:93-96.
159. Hu, S., P. K. Peterson, and C. C. Chao. 1998. Kappa-opioid modulation of human microglial cell Superoxide anion generation. Biochem. Pharmacol. 56:285-288.
160. Hu, S., W. S. Sheng, J. R. Lokensgard, and P. K. Peterson. 2002. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 42:829-836.
161. Hu, S., W. S. Sheng, P. K. Peterson, and C. C. Chao. 1995. Cytokine modulation of murine microglial cell Superoxide production. Glia 13:45-50.
162. Hunter, C. A., and J. Burke. 1997. Neuropathogenesis of African sleeping sickness, p. 189-204. In P. K. Peterson and J. S. Remington (ed.), In defense of the brain: current concepts in the immunopathogenesis and clinical aspects of CNS infections. Blackwell Science, Maiden, Mass.
163. Husemann, J., J. D. Loike, R. Anankov, M. Febbraio, and S. C. Silverstein. 2002. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40:195-205.
164. Ihara, M., H. Tomimoto, M. Kinoshita, J. Oh, M. Noda, H. Wakita, I. Akiguchi, and H. Shibasaki. 2001. Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J. Cereb. Blood Flow Metab. 21:828-834.
165. Inoue, K. 2002. Microglial activation by purines and pyrimidines. Glia 40:156-163.
166. Ivacko, J. A., R. Sun, and F. S. Silverstein. 1996. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr. Res. 39:39-47.
167. Jana, M., X. Liu, S. Koka, S. Ghosh, T. M. Petro, and K. Pahan. 2001. Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J. Biol. Chem. 276:44527-44533.
168. 2alpha production in human microglial cells but not in astrocytes. J. Immunol. 157:2129-2135.
169. Janabi, N., I. Hau, and M. Tardieu. 1999. Negative feedback between prostaglandin and alpha- and beta-chemokine synthesis in human microglial cells and astrocytes. J. Immunol. 162:1701-1706.
170. Jiang, Z. G., C. Piggee, M. P. Heyes, C. Murphy, B. Quearry, M. Bauer, J. Zheng, H. E. Gendelman, and S. P. Markey. 2001. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol. 117:97-107.
171. John, G. R., S. C. Lee, and C. F. Brosnan. 2003. Cytokines: powerful regulators of glial cell activation. Neuroscientist 9:10-22.
172. Kaur, C., A. J. Hao, C. H. Wu, and E. A. Ling. 2001. Origin of microglia. Microsc. Res. Tech. 54:2-9.
173. Kielian, T. 2004. Microglia and chemokines in infectious diseases of the nervous system: views and reviews. Front. Biosci. 9:732-750.
174. Kielian, T., B. Barry, and W. F. Hickey. 2001. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J. Immunol. 166:4634-4643.
175. Kielian, T., P. Mayes, and M. Kielian. 2002. Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression. J. Neuroimmunol. 130:86-99.
176. Kim, Y. S., and M. G. Tauber. 1996. Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production. Infect. Immun. 64:3148-3153.
177. Kitai, R., M. L. Zhao, N. Zhang, L. L. Hua, and S. C. Lee. 2000. Role of MIP-1beta and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNbeta. J. Neuroimmunol. 110:230-239.
178. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
179. Koka, P., K. He, J. A. Zack, S. Kitchen, W. Peacock, I. Fried, T. Tran, S. S. Yashar, and J. E. Merrill. 1995. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J. Exp. Med. 182:941-951.
180. Kotenko, S. V., S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka. 2000. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA 97:1695-1700.
181. Koutsilieri, E., C. Scheller, F. Tribl, and P. Riederer. 2002. Degeneration of neuronal cells due to oxidative stress-microglial contribution. Parkinsonism Relat. Disord. 8:401-406.
182. Kretzschmar, H. A., S. B. Prusiner, L. E. Stowring, and S. J. DeArmond. 1986. Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122:1-5.
183. Laflamme, N., H. Echchannaoui, R. Landmann, and S. Rivest. 2003. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria. Eur. J. Immunol. 33:1127-1138.
184. Laflamme, N., G. Soucy, and S. Rivest. 2001. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J. Neurochem. 79:648-657.
185. Lane, J. H., V. G. Sasseville, M. O. Smith, P. Vogel, D. R. Pauley, M. P. Heyes, and A. A. Lackner. 1996. Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/ microglia and intrathecal immune activation. J. Neurovirol. 2:423-432.
186. Lavi, E., J. M. Strizki, A. M. Ulrich, W. Zhang, L. Fu, Q. Wang, M. O'Connor, J. A. Hoxie, and F. Gonzalez-Scarano. 1997. CXCR-4 (fusin), a coreceptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am. J. Pathol. 151:1035-1042.
187. Lazarini, F., T. N. Tham, P. Casanova, F. Arenzana-Seisdedos, and M. Dubois-Dalcq. 2003. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 42:139-148.
188. Le, W., D. Rowe, W. Xie, I. Ortiz, Y. He, and S. H. Appel. 2001. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J. Neurosci. 21:8447-8455.
189. Lecointe, D., N. Dugas, P. Leclerc, C. Hery, J. F. Delfraissy, and M. Tardieu. 2002. Human cytomegalovirus infection reduces surface CCR5 expression in human microglial cells, astrocytes and monocyte-derived macrophages. Microbes Infect. 4:1401-1408.
190. Ledeboer, A., J. J. P. Breve, A. Wierinckx, S. van der Jagt, A. F. Bristow, J. E. Leysen, F. J. H. Tilders, and A.-M. van Dam. 2002. Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur. J. Neurosci. 16:1175-1185.
191. Lee, S. C., D. W. Dickson, and A. Casadevall. 1996. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum. Pathol. 27:839-847.
192. Lee, S. C., Y. Kress, D. W. Dickson, and A. Casadevall. 1995. Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody. J. Neuroimmunol. 62:43-52.
193. Lee, S. C., Y. Kress, M. L. Zhao, D. W. Dickson, and A. Casadevall. 1995. Cryptococcus neoformans survive and replicate in human microglia. Lab. Investig. 73:871-879.
194. Lee, S. C., W. Liu, C. F. Brosnan, and D. W. Dickson. 1992. Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab. Investig. 67:465-476.
195. Lee, S. C., W. Liu, D. W. Dickson, C. F. Brosnan, and J. W. Berman. 1993. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150:2659-2667.
196. Lee, Y. B., A. Nagai, and S. V. Kim. 2002. Cytokines, chemokines, and cytokine receptors in human microglia. J. Neurosci. Res. 69:94-103.
197. Leonard, J. M., and R. M. Des Prez. 1990. Tuberculous meningitis. Infect. Dis. Clin. North Am. 4:769-787.
198. Li, J., B. Gran, G. X. Zhang, E. S. Ventura, I. Siglienti, A. Rostami, and M. Kamoun. 2003. Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J. Neurol. Sci. 215:95-103.
199. Licinio. J., and M. L. Wong. 1997. Pathways and mechanisms for cytokine signaling of the central nervous system. J. Clin. Investig. 100:2941-2947.
200. Ling, E. A., and W. C. Wong. 1993. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7:9-18.
201. Lipovsky, M. M, G. Gekker, W. R. Andersen, T. W. Molitor, P. K. Peterson, and A. I. Hoepelman. 1997. Phagocytosis of nonopsonized Cryptococcus neoformans by swine microglia involves CD14 receptors. Clin. Immunol. Immunopathol. 84:208-211.
202. Lipovsky, M. M., G. Gekker, S. Hu, L. C. Ehrlich, A. I. Hoepelman, and P. K. Peterson. 1998. Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J. Infect. Dis. 177:260-263.
203. Lipovsky, M. M., G. Gekker, S. Hu, A. I. Hoepelman, and P. K. Peterson. 1998. Morphine enhances complement receptor-mediated phagocytosis of Cryptococcus neoformans by human microglia. Clin. Immunol. Immunopathol. 87:163-167.
204. Lipovsky, M. M., A. E. Juliana, G. Gekker, S. Hu, A. I. Hoepelman, and P. K. Peterson. 1998. Effect of cytokines on anticryptococcal activity of human microglial cells. Clin. Diagn. Lab. Immunol. 5:410-411.
205. Lipton. S. A., and H. E. Gendelman. 1995. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332:934-940.
206. Liu, B., L. Du, and J. S. Hong. 2000. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and Superoxide generation. J. Pharmacol. Exp. Ther. 293:607-617.
207. Liu, B., H. M. Gao, and J. S. Hong. 2003. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Perspect. 111:1065-1073.
208. Liu, B., and J. S. Hong. 2003. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304:1-7.
209. Liu, Y., L. Qin, G. Li, W. Zhang, L. An, B. Liu, and J. S. Hong. 2003. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J. Pharmacol. Exp. Ther. 305:212-218.
210. Liuzzi, G. M., M. P. Santacroce, W. J. Peumans, E. J. Van Damme, B. Dubois, G. Opdenakker, and P. Riccio. 1999. Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins. Glia 27:53-61.
211. Lodge, P. A., and S. Sriram. 1996. Regulation of microglial activation by TGB-beta, IL-10, and CSF-1. J. Leukoc. Biol. 60:502-508.
212. Lokensgard, J. R., C. C. Chao, G. Gekker, S. Hu, and P. K. Peterson. 1998. Benzodiazepines, glia, and HIV-1 neuropathogenesis. Mol. Neurobiol. 18: 23-33.
213. Lokensgard, J. R., M. C. Cheeran, G. Gekker, S. Hu, C. C. Chao, and P. K. Peterson. 1999. Human cytomegalovirus replication and modulation of apoptosis in astrocytes. J. Hum. Virol. 2:91-101.
214. Lokensgard, J. R., M. C. Cheeran, S. Hu, G. Gekker, and P. K. Peterson. 2002. Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J. Infect. Dis. 186(Suppl. 2):S171-S179.
215. Lokensgard, J. R., G. Gekker, S. Hu, A. F. Arthur, C. C. Chao, and P. K. Peterson. 1997. Diazepam-mediated inhibition of human immunodeficiency virus type 1 expression in human brain cells. Antimicrob. Agents Chemother. 41:2566-2569.
216. Lokensgard, J. R., S. Hu, C. C. Hegg, S. A. Thayer, G. Gekker, and P. K. Peterson. 2001. Diazepam inhibits HIV-1 Tat-induced migration of human microglia. J. Neurovirol. 7:481-486.
217. Lokensgard, J. R., S. Hu, W. Sheng, M. vanOijen, D. Cox, M. C. Cheeran, and P. K. Peterson. 2001. Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J. Neurovirol. 7:208-219.
218. Lorenzl, S., D. S. Albers, S. Narr, J. Chirichigno, and M. F. Beal. 2002. Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease. Exp. Neurol. 178:13-20.
219. Luder, C. G., M. Giraldo-Velasquez, M. Sendtner, and U. Gross. 1999. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp. Parasitol. 93:23-32.
220. Luder, C. G., C. Lang, M. Giraldo-Velasquez, M. Algner, J. Gerdes, and V. Gross. 2003. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA. J. Neuroimmunol. 134:12-24.
221. Maciejewski-Lenoir, D., S. Chen, L. Feng, R. Maki, and K. B. Bacon. 1999. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J. Immunol. 163:1628-1635.
222. Maeda, A., and R. A. Sobel. 1996. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55:300-309.
223. Mahalingam, S, J. M. Farber, and G. Karupiah. 1999. The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo. J. Virol. 73:1479-1491.
224. Male, D., and P. Rezaie. 2001. Colonisation of the human central nervous system by microglia: the roles of chemokines and vascular adhesion molecules. Prog. Brain Res. 132:81-93.
225. Mallat, M., and B. Chamak. 1994. Brain macrophages: neurotoxic or neurotrophic effector cells? J. Leukoc. Biol. 56:416-422.
226. Manuelidis, L, W. Fritch, and Y. G. Xi. 1997. Evolution of a strain of CJD that induces BSE-like plaques. Science 277:94-98.
227. Marella, M., and J. Chabry. 2004. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J. Neurosci. 24:620-627.
228. Marzolo, M. P., R. von Bernhardi, and N. C. Inestrosa. 1999. Mannose receptor is present in a functional state in rat microglial cells. J. Neurosci. Res. 58:387-395.
229. Maschke, M., O. Kastrup, S. Esser, B. Ross, V. Hengge, and A. Hufnagel. 2000. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J. Neurol. Neurosurg. Psychiatry 69:376-380.
230. Mathisen, G. E., and J. P. Johnson. 1997. Brain abscess. Clin. Infect. Dis. 25:763-779; quiz, 780-781.
231. Mayer, A. M., M. Hall, M. J. Fay, P. Lamar, C. Pearson, W. C. Prozialeck, V. K. Lehmann, P. B. Jacobson, A. M. Romanic, T. Uz, and H. Manev. 2001. Effect of a short-term in vitro exposure to the marine toxin domoic acid on viability, tumor necrosis factor-alpha, matrix metalloproteinase-9 and superoxide anion release by rat neonatal microglia. BMC Pharmacol. 1:7.
232. Mazzolla, R., R. Barluzzi, A. Brozzetti, J. R. Boelaert, T. Luna, S. Saleppico, F. Bistoni, and E. Blasi. 1997. Enhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitis. Antimicrob. Agents Chemother. 41:802-807.
233. McCarthy, M., D. Auger, and S. R. Whittemore. 2000. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J. Hum. Viral. 3:215-228.
234. McCarthy, M., J. He, and C. Wood. 1998. HIV-1 strain-associated variability in infection of primary neuroglia. J. Neurovirol. 4:80-89.
235. McCarthy, M., C. Wood, L. Fedoseyeva, and S. R. Whittemore. 1995. Media components influence viral gene expression assays in human fetal astrocyte cultures. J. Neurovirol. 1:275-285.
236. McGeer, P. L., and E. G. McGeer. 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:195-218.
237. McGrath, N., N. E. Andersen, M. C. Croxson, and K. F. Powell. 1997. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J. Neurol. Neurosurg. Psychiatry 63:321-326.
238. McHattie, S. J., D. R. Brown, and M. M. Bird. 1999. Cellular uptake of the prion protein fragment PrP106-126 in vitro. J. Neurocytol. 28:149-159.
239. McManus, C. M., C. F. Brosnan, and J. W. Herman. 1998. Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia. J. Immunol. 160:1449-1455.
240. Meda, L., P. Baron, E. Prat, E. Scarpini, G. Scarlato, M. A. Cassatella, and F. Rossi. 1999. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J. Neuroimmunol. 93:45-52.
241. Medana, I. M., T. Chan-Ling, and N. H. Hunt. 2000. Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier. Am. J. Pathol. 156:1055-1065.
242. Medana, I. M., N. H. Hunt, and T. Chan-Ling. 1997. Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia 19:91-103.
243. Medana, I. M., N. H. Hunt, and G. Chaudhri. 1997. Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am. J. Pathol. 150:1473-1486.
244. Merrill, J. E. 1992. Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunother. 12:167-170.
245. Messam, C. A., and E. O. Major. 2000. Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. J. Neurovirol. 6(Suppl. 1):S90-S94.
246. Meucci, O., A. Fatatis, A. A. Simen, and R. J. Miller. 2000. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 97:8075-8080.
247. Meyding-Lamade, U., J. Haas, W. Lamade, K. Stingele, R. Kehm, A. Fath, K. Heinrich, B. Storch Hagenlocher, and B. Wildemann. 1998. Herpes simplex virus encephalitis: long-term comparative study of viral load and the expression of immunologic nitric oxide synthase in mouse brain tissue. Neurosci. Lett. 244:9-12.
248. Minagar, A., P. Shapshak, R. Fujimura, R. Ownby, M. Heyes, and C. Eisdorfer. 2002. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 202:13-23.
249. Minton, K. 2001. Immune mechanisms in neurological disorders: protective or destructive? Trends Immunol. 22:655-657.
250. Mittelbronn, M., K. Dietz, H. J. Schluesener, and R. Meyermann. 2001. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magniture. Acta Neuropathol. 101: 249-255.
251. Monje, M. L., H. Toda, and T. D. Palmer. 2003. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760-1765.
252. Monsonego, A., J. Imitola, V. Zota, T. Oida, and H. L. Weiner. 2003. Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to ThI cells. J. Immunol. 171:2216-2224.
253. Monsonego, A., and H. L. Weiner. 2003. Immunotherapeutic approaches to Alzheimer's disease. Science 302:834-838.
254. Morner, A., J. A. Thomas, E. Bjorling, P. J. Munson, S. B. Lucas, and A. McKnight. 2003. Productive HIV-2 infection in the brain is restricted to macrophages/microglia. AIDS 17:1451-1455.
255. Moser, M., R. J. Colello, U. Pott, and B. Oesch. 1995. Developmental expression of the prion protein gene in glial cells. Neuron 14:509-517.
256. Moss, D. W., and T. E. Bates. 2001. Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur. J. Neurosci. 13:529-538.
257. Murphy, G. M., Jr., X. C. Jia, Y. Song, E. Ong, R. Shrivastava, V. Bocchini, Y. L. Lee, and L. F. Eng. 1995. Macrophage inflammatory protein 1-alpha mRNA expression in an immortalized microglial cell line and cortical astrocyte cultures. J. Neurosci. Res. 40:755-763.
258. Murray, H. W., B. Y. Rubin, H. Masur, and R. B. Roberts. 1984. Impaired production of lymphokines and immune (gamma) Interferon in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310:883-888.
259. Nagai, A., E. Nakagawa, K. Hatori, H. B. Choi, J. G. McLarnon, M. A. Lee, and S. U. Kim. 2001. Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines. Neurobiol. Dis. 8:1057-1068.
260. Nakamura, Y. 2002. Regulating factors for microglial activation. Biol. Pharm. Bull. 25:945-953.
261. Nebuloni, M, A. Pellegrinelli, A. Ferri, A. Tosoni, S. Bonetto, P. Zerbi, R. Boldorini. L. Vago, and G. Costanzi. 2000. Etiology of microglial nodules in brains of patients with acquired immunodeficiency syndrome. J. Neurovirol. 6:46-50.
262. Nelson, P. T., L. A. Soma, and E. Lavi. 2002. Microglia in diseases of the central nervous system. Ann. Med. 34:491-500.
263. New, D. R., M. Ma, L. G. Epstein, A. Nath, and H. A. Gelbard. 1997. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3:168-173.
264. Nguyen, M. D., J. P. Julien, and S. Rivest. 2002. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3:216-227.
265. Nishiyori, A., M. Minami, Y. Ohtani, S. Takami, J. Vamamoto, N. Kawaguchi, T. Kume, A. Akaike, and M. Satoh. 1998. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett. 429:167-172.
266. Nottet, H. S., M. Jett, C, R. Flanagan, Q. H. Zhai, Y. Persidsky, A. Rizzino, E. W. Bernton, P. Genis, T. Baldwin, J. Schwartz, et al. 1995. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154:3567-3581.
267. Nuovo, G. J., and M. L. Alfleri. 1996. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol. Med. 2:358-366.
268. Ogata, T., M. Chuai, T. Morino, H. Yamamoto, Y. Nakamura, and P. Schubert. 2003. Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors. Brain Res, 981: 174-183.
269. O'Keefe, G. M, V. T. Nguyen, and E. N. Benveniste. 2002. Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: implications in neurological diseases. J. Neurovirol. 8:496-512.
270. Olsson, T., M. Bakhiet, B. Hojeberg, A. Ljungdahl, C. Edlund, G. Andersson, H. P. Ekre, W. P. Fung-Leung, T. Mak, H. Wigzell, et al. 1993. CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell 72:715-727.
271. Overmyer, M., S. Helisalmi, H. Soininen, M. Laakso, P. Riekkinen, Sr., and I. Alafuzoff. 1999. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue. Acta Neuropathol. 97:383-392.
272. Park, J. H., and S. H. Shin. 1996. Induction of IL-12 gene expression in the brain in septic shock. Biochem. Biophys. Res. Commun. 224:391-396.
273. Perry, V. H., and L. J. Lawson. 1992. Macrophages in the central nervous system, p. 393-413. in C. Lewis (ed.), The macrophage. Oxford University Press, Oxford, United Kingdom.
274. Persidsky, Y., and H. E. Gendelman. 2003. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J. Leukoc. Biol. 74: 691-701.
275. Persidsky, Y., A. Ghorpade, J. Rasmussen, J. Limoges, X. J. Liu, M. Stins, M. Fiala, D. Way, K. S. Kim, M. H. Witte, M. Weinand, L. Carhart, and H. E. Gendelman. 1999. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155:1599-1611.
276. Peterson, P. K., G. Gekker, M., Bornemann, D. Chatterjee, and C. C. Chao. 1995. Thalidomide inhibits lipoarabinomannan-induced upregulation of human immunodeficiency virus expression. Antimicrob. Agents Chemother. 39:2807-2809.
277. Peterson, P. K., G. Gekker, S. Hu, W. B. Andersen, M. Teichert, C. C. Chao, and T. W. Molitor. 1996. Multinucleated giant cell formation of swine microglia induced by Mycobacterium bovis. J. Infect. Dis. 173:1194-1201.
278. Peterson, P. K., G. Gekker, S. Hu, and C. C. Chao. 1997. Microglia: a "double-edged sword," p. 31-55. In P. K. Peterson and J. S. Remington (ed.), In defense of the brain: current concepts in the immunopathogenesis and clinical aspects of CNS infections. Blackwell Science, Maiden, Mass.
279. Peterson, P. K., G. Gekker, S. Hu, J. Lokensgard, P. S. Portoghese, and C. C. Chao. 1999. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor. Neuropharmacology 38:273-278.
280. Peterson, P. K., G. Gekker, S. Hu, W. S. Sheng, W. R. Andersen, R. J. Ulevitch, P. S. Tobias, K. V. Gustafson, T. W. Molitor, and C. C. Chao. 1995. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun. 63:1598-1602.
281. Peterson, P. K., G. Gekker, S. Hu, W. S. Sheng, T. W. Molitor, and C. C. Chao. 1995. Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor. Adv. Neuroimmunol. 5:299-309.
282. Peterson, P. K., S. Hu, W. R. Andersen, and C. C. Chao. 1994. Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J. Infect. Dis. 170:457-460.
283. Peterson, P. K., S. Hu, J. Salak-Johnson, T. W. Molitor, and C. C. Chao. 1997. Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J. Infect. Dis. 175:478-481.
284. Peterson, P. K., S. Hu, W. S. Sheng, F. H. Kravitz, T. W. Molitor, D. Chatterjee, and C. C. Chao. 1995. Thalidomide inhibits tumor necrosis factor-alpha production by lipopolysaccharide- and lipoarabinomannan-stimulated human microglial cells. J. Infect. Dis. 172:1137-1140.
285. Peudenier, S., C. Hery, L. Montagnier, and M. Tardieu. 1991. Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann. Neurol. 29:152-161.
286. Peyrin, J. M., C. I. Lasmezas, S. Haik, F. Tagliavini, M. Salmona, A. Williams, D. Richie, J. P. Deslys, and D. Dormont. 1999. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 10:723-729.
287. Pfister, H. W., W. Feiden, and K. M. Einhaupl. 1993. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch. Neurol. 50:575-581.
288. Philip, K. A., M. J. Dascombe, P. A. Fraser, and V. W. Pentreath. 1994. Blood-brain barrier damage in experimental African trypanosomiasis. Ann. Trop. Med. Parasitol. 88:607-616.
289. Poland, S. D., L. L. Bambrick, G. A. Dekaban, and G. P. Rice. 1994. The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation. J. Infect. Dis. 170:1267-1271.
290. Polfliet, M. M. J., F. van de Veerdonk, E. A. Dopp, E. M. L. van Kesteren-Hendrikx, N. van Rooijen, C. D. Dijkstra, and T. K. van den Berg. 2002. The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis. J. Neuroimmunol. 122:1-8.
291. Polfliet, M. M. J., P. J. G. Zwijnenburg, A, M. van Furth, T. van der Poll, E. A. Dopp, C. R. de Lavalette, E. M. L. van Kesteren-Hendrikx, N. van Rooijen, C. D. Dijkstra, and T. K. van den Berg. 2001. Meningeal and perivascular macrophages of the central nervous system play a progective role during bacterial meningitis. J. Immunol. 167:4644-4650.
292. Pratt, B. M., and J. M. McPherson. 1997. TGF-beta in the central nervous system: potential roles in ischimic injoury and neurodegenerative diseases. Cytokine Growth Factor Rev. 8:267-292.
293. Prusiner, S. B. 1991. Molecular biology of prion diseases. Science 252: 1515-1522.
294. Pulliam, L., J. A. Clarke, D. McGuire, and M. S. McGrath. 1994. Investigation of HIV-infected macrophage neurotoxin production from patients with AIDS dementia. Adv. Neuroimmunol. 4:195-198.
295. Pulliam, L., D. Moore, and D. C. West. 1995. Human cytomegalovirus induces 1L-6 and TNF alpha from macrophages and microglial cells: possible role in neurotoxicity. J. Neurovirol. 1:219-227.
296. Rasley, A., J. Anguita, and I. Marriott. 2002. Borrelia burgdorfen induces inflammatory mediator production by murine microglia. J. Neuroimmunol. 130:22-31.
297. Reddehase, M. J. 2000. The immunogenicity of human and murine cytomegaloviruses. Curr. Opin. Immunol. 12:738.
298. Ren, L. Q., N. Gourmala, H. W. Boddeke, and P. J. Gebicke-Haerter. 1998. Lipopolysaccharide-induced expression of IP-10 mRNA in rat brain and in cultured rat astrocytes and microglia. Brain. Res. Mol. Brain. Res. 59:256-263.
299. Rezaie, P., and P. L. Lantos. 2001. Microglia and the pathogenesis of spongiform encephalopathies. Brain Res. Rev. 35:55-72.
300. Rezaie, P., G. Trillo-Pazos, I. P. Everall, and D. K. Male. 2002. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 37:64-75.
301. Rezaie, P., G. Trillo-Pazos, J. Greenwood, I. P. Everall, and D. K. Male. 2002. Motility and ramification of human fetal microglia in culture: an investigation using time-lapse video microscopy and image analysis. Exp. Cell Res. 274:68-82.
302. Rietschel, E. T., and H. Brade. 1992. Bacterial endotoxins. Sci. Am. 267: 54-61.
303. Ring, A., J. N. Weiser, and E. I. Tuomanen. 1998. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J. Clin. Investig. 102:347-360.
304. Rogers, J., and L. F. Lue. 2001. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39:333-340.
305. Rosenberg, G. A., L. A. Cunningham, J. Wallace, S. Alexander, E. Y. Estrada, M. Grossetete, A. Razhagi, K. Miller, and A. Gearing. 2001. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893:104-112.
306. Rosenberg, G. A., N. Sullivan, and M. M. Esiri. 2001. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 32:1162-1168.
307. Rosenstiel, P., R. Lucius, G. Deuschl, J. Sievers, and H. Wilms. 2001. From theory to therapy: implication from an in vitro model of ramified microglia. Microsc. Res. Tech. 54:18-25.
308. Rothwell, N. J. 1998. Interleukin-1 and neurodegeneration. Neuroscientist 4:195-201.
309. Rozenfeld, C., R. Martinez, R. T. Figueiredo, M. T. Bozza, F. R. Lima, A. L. Pires, P. M. Suva, A. Bonomo, J. Lannes-Vieira, W. De Souza, and V. Moura-Neto. 2003. Soluble factors released by Toxoplasma gondii-injected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect. Immun. 71:2047-2057.
310. Saito, Y., L. R. Sharer, L. G. Epstein, J. Michaels, M. Mintz, M. Louder, K. Golding, T. A. Cvetkovich, and B. M. Blumberg. 1994. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44:474-481.
311. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Laponmeroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Georges, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R. W. Doms, G. Vassart, and M. Parmentier. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
312. Sapp, E., K. B. Kegel, N. Aronin, T. Hashikawa, Y. Uchiyama, K. Tohyama, P. G. Bhide, J. P. Vonsattel, and M. DiFiglia. 2001. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 60:161-172.
313. Scheid, W. M., U. Koedel, B. Nathan, and H. W. Pfister. 2002. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J. Infect. Dis. 186(Suppl. 2):S225-S233.
314. Schluesener, H. J., P. G. Kremsner, and R. Meyermann. 2001. Heme oxygenase-1 in lesions of human cerebral malaria. Acta Neuropathol. 101: 65-68.
315. Schluesener, H. J., P. G. Kremsner, and R. Meyermann. 1998. Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells. Acta Neuropathol. 96:575-580.
316. Schluter, D., N. Kaefer, H. Hof, O. D. Wiestler, and M. Deckert-Schluter. 1997. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am. J. Pathol. 150:1021-1035.
317. Schluter, D., L. Y. Kwok, S. Lutjen, S. Soltek, S. Hoffmann, H. Korner, and M. Deckert. 2003. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J. Immunol. 170:6172-6182.
318. Schubert, P., T. Ogata, C. Marchini, and S. Ferroni. 2001. Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target? Mech. Ageing Dev. 123:47-57.
319. Schut, R. L., G. Gekker, S. Hu, C. C. Chao, C. Pomeroy, M. C. Jordan, and P. K. Peterson. 1994. Cytomegalovirus replication in murine microglial cell cultures: suppression of permissive infection by interferon-gamma. J. Infect. Dis. 169:1092-1096.
320. Schwab, J. M., H. J. Schluesener, K. Seid, and R. Meyermann. 2001. IL-16 is differentially expressed in the developing human fetal brain by microglial cells in zones of neuropoesis. Int. J. Dev. Neurosci. 19:93-100.
321. Shams, H., B. Wizel, D. L. Lakey, B. Samten, R. Vankayalapati, R. H. Valdivia, R. L. Kitchens, D. E. Griffith, and P. F. Barnes. 2003. The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. FEMS Immunol. Med. Microbiol. 36:63-69.
322. Sheng, W. S., S. Hu, C. C. Hegg, S. A. Thayer, and P. K. Peterson. 2000. Activation of human microglial cells by HIV-1 gp41 and Tat proteins. Clin. Immunol. 96:243-251.
323. Shieh, J. T., A. V. Albright, M. Sharron, S. Gartner, J. Strizki, R. W. Doms, and F. Gonzalez-Scarano. 1998. Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J. Virol. 72:4243-4249.
324. Shimeld, C., J. L. Whiteland, S. M. Nicholls, E. Grinfeld, D. L. Easty, H. Gao, and T. J. Hill. 1995. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61:7-16.
325. Shimeld, C., J. L. Whiteland, N. A. Williams, D. L. Easty, and T. J. Hill. 1997. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J. Gen. Virol. 78:3317-3325.
326. Shrikant, P., and N. Benveniste. 1996. The central nervous system as an immunocompetent organ. J. Immunol. 157:1819-1822.
327. Si, Q., M. Cosenza, M. L. Zhao, H. Goldstein, and S. C. Lee. 2002. GM-CSF and M-CSF modulate beta-chemokine and HlV-1 expression in microglia. Glia 39:174-183.
328. Si, Q., M. O. Kim, M. L. Zhao, N. R. Landau, H. Goldstein, and S. Lee. 2002. Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells. Virology 301:342-353.
329. Simpson, J. E., J. Newcombe, M. L. Cuzner, and M. N. Woodroofe. 1998. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 84:238-249.
330. Skiest, D. J. 2002. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin. Infect. Dis. 34:103-115.
331. Skoldenberg, B. 1996. Herpes simplex encephalitis. Scand. J. Infect. Dis. Suppl. 100:8-13.
332. Smith, M. E. 2001. Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE. Microsc. Res. Tech. 54:81-94.
333. Song, X., S. Shapiro, D. L. Goldman, A. Casadevall, M. Scharff. and S. C. Lee. 2002. Fc gamma receptor I- and III-mediated macrophage inflammatory protein 1α induction in primary human and murine microglia. Infect. Immun. 70:5177-5184.
334. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Stricter, J. L. Frederiksen, and R. M. Ransohoff. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Investig. 103:807-815.
335. Sowa, G., G. Gekker, M. M. Lipovsky, S. Hu, C. C. Chao, T. W. Molitor, and P. K. Peterson. 1997. Inhibition of swine microglial cell phagocytosis of Cryptococcus neoformans by femtomolar concentrations of morphine. Biochem. Pharmacol. 53:823-828.
336. Spranger, M., and A. Fontana. 1996. Activation of microglia: a dangerous interlude in immune function in the brain. Neuroscientist. 2:293-299.
337. Stalder, A. K., A. Pagensteeher, N. C. Yu, C. Kincaid, C.-S. Chiang, M. V. Hobbs, F. E. Bloom, and I. L. Campbell. 1997. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J. Immunol. 159:1344-1351.
338. Stoll, G., S. Jander, and M. Schroeter. 2002. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv. Exp. Med. Biol. 513:87-113.
339. Strack, A., V. C. Asensio, I. L. Campbell, D. Schluter, and M. Decken. 2002. Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathol. 103:458-468.
340. Streit, W. J. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133-139.
341. Streit, W. J. 1995. Microglial cells, p. 85-96. In H. Kettenmann and B. R. Ransom (ed.), Neuroglia. Oxford University Press, New York, N.Y.
342. Streit, W. J. 1993. Microglial-neuronal interactions. J. Chem. Neuroanat. 6:261-266.
343. Streit, W. J., M. B. Graeber, and G. W. Kreutzberg. 1988. Functional plasticity of microglia: a review. Glia 1:301-307.
344. Suzuki, Y. 2002. Host resistance in the brain against Toxoplasma gondii. J. Infect. Dis. 185(Suppl. 1):S58-S65.
345. Suzuki, Y., and K. Job. 1994. Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma. Parasitol. Res. 80:125-130.
346. Szczepanik, A. M., S. Funes, W. Petko, and G. E. Ringheim. 2001. IL-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J. Neuroimmunol. 113:49-62.
347. Taramelli, D., N. Basilico, E. Pagani, R. Grande, D. Monti, M. Ghione, and P. Olliaro. 1995. The heme moiety of malaria pigment (beta-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-alpha production by lipopolysaccharide-stimulated macrophages. Exp. Parasitol. 81:501-511.
348. Taramelli, D., S. Recalcati, N. Basilico, P. Olliaro, and G. Cairo. 2000. Macrophage preconditioning with synthetic malaria pigment reduces cytokine production via heme iron-dependent oxidative stress. Lab. Investig. 80:1781-1788.
349. Taylor, D. L., L. T. Diemel, and J. M. Pocock. 2003. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J. Neurosci. 23:2150-2160.
350. Thomas, E. W. 1992. Brain macrophages: evaluation of microglia and their functions. Brain Res. Rev. 17:61-74.
351. Thomas, E. W. 1999. Brain macrophages: on the role of pericytes and perivascular cells. Brain Res. Rev. 31:42-57.
352. Tikka, T. M., and J. E. Koistinaho. 2001. Minocycline provides neuroprotection against N-methyl-1-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166:7527-7533.
353. Tornatore, C., A. Nath, K. Amemiya, and E. O. Major. 1991. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J. Virol. 65:6094-6100.
354. Townsend, G. C., and W. M. Scheld. 1998. Infections of the central nervous system. Adv. Intern. Med. 43:403-447.
355. Trillo-Pazos, G., A. Diamanturos, L. Rislove, T. Menza, W. Chao, P. Belem, S. Sadiq, S. Morgello, L. Sharer, and D. J. Volsky. 2003. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol. 13:144-154.
356. Tsuda, M., A. Mizokoshi, Y. Shigemoto-Mogami, S. Koizumi, and K. Inoue. 2004. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45:89-95.
357. Ulvestad, E., K. Williams, S. Mork, J. Antel, and H. Nyland. 1994. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J. Neuropathol. Exp. Neurol. 53:492-501.
358. Vallat-Decouvelaere, A. V., F. Chretien, G. Gras, G. Le Pavec, D. Dorment, and F. Gray. 2003. Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A neuroprotective role for activated microglia? J. Neuropathol. Exp. Neurol. 62:475-485.
359. van de Beek, D., J. de Gans, P. McIntyre, and K. Prasad. 2003. Corticosteroids in acute bacterial meningitis. Cochrane Database Syst. Rev. 2003: CD004305.
360. Van Everbroeck, B., E. Dewulf, P. Pals, U. Lubke, J. J. Martin, and P. Cras. 2002. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol. Aging 23:59-64.
361. Veerhuis, R., J. J. Hoozemans, I. Janssen, R. S. Boshuizen, J. P. Langeveld, and P. Eikelenboom. 2002. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2. Brain Res. 925:195-203.
362. Verderio, C., and M. Matteoli. 2001. ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J. Immunol. 166:6383-6391.
363. Vila, M., V. Jackson-Lewis, C. Guegan, D. C. Wu, P. Teismann, D. K. Choi, K. Tieu, and S. Przedborski. 2001. The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 14:483-489.
364. Voyvodic, J. T. 1996. Cell death in cortical development: how much? Why? So what? Neuron 16:81-90.
365. Waksman, Y., J. M. Olson, S. J. Carlisle, and G. A. Cabral. 1999. The central cannabinoid receptor (CBI) mediates inhibition of nitric oxide production by rat microglial cells. J. Pharmacol. Exp. Ther. 288:1357-1366.
366. Walker, D. G., S. Itagaki, K. Berry, and P. L. McGeer. 1989. Examination of brains of AIDS cases for human immunodeficiency virus and human cytomegalovirus nucleic acids. J. Neurol. Neurosurg. Psychiatry 52:583-590.
367. Walker, D. G., L. F. Lue, and T. G. Beach. 2001. Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol. Aging 22:957-966.
368. Wang, J., K. Crawford, M. Yuan, H. Wang, P. R. Gorry, and D. Gabuzda. 2002. Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines. J. Infect. Dis. 185:885-897.
369. Watkins, L. R., E. D. Milligan, and S. F. Maier. 2003. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv. Exp. Med. Biol. 521:1-21.
370. Weinstein, D. L., D. G. Walker, H. Akiyama, and P. L. McGeer. 1990. Herpes simplex virus type I infection of the CNS induces major histocompatibility complex antigen expression on rat microglia. J. Neurosci. Res. 26:55-65.
371. Wierzba-Bobrowicz, T., E. Gwiazda, E. Kosno-Kruszewska, E. Lewandowska, W. Lechowicz, E. Bertrand, G. M. Szpak, and B. Schmidt-Sidor. 2002. Morphological analysis of active microglia-rod and ramified microglia in human brains affected by some neurological diseases (SSPE, Alzheimer's disease and Wilson's disease). Folia Neuropathol. 40:125-131.
372. Wildemann, B., K. Ehrhart, B. Storch-Hagenlocher, U. Meyding-Lamade, S. Steinvorth, W. Haeke, and J. Haas. 1997. Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology 48:1341-1346.
373. Wiley, C. A., R. D. Schrier, J. A. Nelson, P. W. Lampert, and M. B. Oldstone. 1986. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83:7089-7093.
374. Will, R. G., J. W. Ironside, M. Zeidler, S. N. Cousens, K. Estibeiro, A. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, and P. G. Smith. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925.
375. Williams, A., P. J. Lucassen, D. Ritchie, and M. Bruce. 1997. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp. Neurol. 144:433-438.
376. Williams, E., X. Alvarez, and A. A. Lackner. 2001. Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36:156-164.
377. Williams, K., N. Dooley, E. Ulvestad, B. Becher, and J. P. Antel. 1996. IL-10 production by adult human derived microglial cells. Neurochem. Int. 29: 55-64.
378. Williams, K. C., S. Corey, S. V. Westmoreland, D. Pauley, H. Knight, C. deBakker, X. Alvarez, and A. A. Lackner. 2001. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 193:905-915.
379. Williams, K. C., and W. F. Hickey. 2002. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25:537-562.
380. Xia, M. Q., and B. T. Hyman. 1999. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 5:32-41.
381. Xia, M. Q., S. X. Qin, L. J. Wu, C. R. Mackay, and B. T. Hyman. 1998. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am. J. Pathol. 153:31-37.
382. Xiong, H., J. Boyle, M. Winkelbauer, S. Gorantla, J. Zheng, A. Ghorpade, Y. Persidsky, K. A. Carlson, and H. E. Gendelman. 2003. Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. J. Neurosci. Res. 71:600-607.
383. Ying Wang, J., F. Peruzzi, A. Lassak, L. Del Valle, S. Radhakrishnan, J. Rappaport, K. Khalili, S. Amini, and K. Reiss. 2003. Neuroprotective effects of IGF-1 against TNFalpha-induced neuronal damage in HIV-associated dementia. Virology 305:66-76.
384. Yoshiyama, Y., H. Sato, M. Seiki, A. Shinagawa, M. Takahashi, and T. Yamada. 1998. Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues. Acta Neuropathol. 96:347-350.
385. Zehntner, S. P., M. Brisebois, E. Tran, T. Owens, and S. Fournier. 2003. Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease. FASEB J. 17: 1910-1912.
386. Zysk, G., W. Bruck, J. Gerber, Y. Bruck, H. W. Prange, and R. Nau. 1996. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 55:722-728.